ClinicalTrials.gg
Sign In

Drug

LY3214996 clinical trials

Also written LY3214996.

studies test it
5
open now
0
in phase 3
0
first study started
2019

How studies write it

Studies that test it under each name

Development codes

LY3214996
5

Studies by the year they started

5 studies that test it; most in 2020 (3)

Studies that test LY3214996, by start year
YearStudies
20191
20203
20221

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
3
Phase 2
1

What it is tested for

Each study’s main condition, where its own words name it.

Glioblastoma
1
Leukemia, Myeloid, Acute
1

Who runs them

Industry 1 · Other 4

Nader Sanai (1) · Dana-Farber Cancer Institute (1) · Eli Lilly and Company (1) · The Netherlands Cancer Institute (1) · Anita Turk (1)

Often tested with

Tested in the same studies.

Abemaciclib (2) · Vociprotafib (1)

Studies

Open first, then newest update. How each study uses LY3214996 is read from its arms, and is right about nine times in ten.

Testing it · 5

Given in every arm · 4 — LY3214996 is usual care beside what is tested